Specify a stock or a cryptocurrency in the search bar to get a summary
Eton Pharmaceuticals Inc
ETONEton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois. Address: 21925 W. Field Parkway, Deer Park, IL, United States, 60010-7278
Analytics
WallStreet Target Price
10.5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ETON
Dividend Analytics ETON
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ETON
Stock Valuation ETON
Financials ETON
Results | 2019 | Dynamics |